Follow our blog for the latest news and insights from our experts to stay at the forefront of the industry.
We are proud to congratulate Dr. Beth Shaz, Executive Vice President, Chief Medical and Scientific Officer of NYBC on being named one of Crain’s Notable Women in Healthcare.
CCS offers a comprehensive menu of products and services to develop, improve, and implement scientific studies in the areas of regenerative medicine, cell therapies, transfusion medicine, and related scientific and medical endeavors.
“… this approach has the potential to be one of the first routine uses of genomics for medical care for patients needing blood transfusion.” - Connie Westhoff, SBB PhD
Gene therapy to cure sickle cell anemia (SCA), caused by having two copies of the hemoglobin S gene mutation, is an exciting new therapy.
Our researchers explore the therapeutic use of patients' own blood cells to treat solid tumors.
Comprehensive Cell Solutions™ (CCS) leverages NYBC's strengths of innovation, flexibility, mobility, creativity, and quality.
At every step in the pipeline.
Stay at the forefront of the industry.
Don't see what you're looking for? Please ask!